Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development
March 22, 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 22, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum
March 20, 2023 06:45 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 20, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic multi-year...
Syneos Health Unveils New Decentralized Clinical Trial Site Network to Drive DCT Adoption
February 28, 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the launch of a Decentralized...
Syneos Health Reports Fourth Quarter and Full Year 2022 Results
February 16, 2023 06:03 ET
|
Syneos Health, Inc.
Revenue for the fourth quarter of $1,359.9 million decreased 1.0% on a reported basis and increased 1.7% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health Schedules Fourth Quarter and Full Year 2022 Earnings Call for Thursday, February 16th, 2023
February 08, 2023 21:41 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year...
Syneos Health Partners with Equicare, Optimizing Data Capture and Integration to Accelerate Clinical Trial Research
February 08, 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AI
February 07, 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab
January 11, 2023 07:10 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health Dealmakers’ Intentions Survey Sees “Optimism” for M&A and Licensing Deals in 2023
January 10, 2023 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 13th annual Dealmakers’...
Syneos Health Announces Chief Financial Officer Transition
January 09, 2023 16:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that, effective March 31,...